Target intelligence / Profile preview

Azide (N3-)

Target
N3-
Molecular classification
Inorganic anion, Enzyme inhibitor, Chemical functional group
01

Overview

Azide is an inorganic anion (N3-) that is widely recognized as a potent metabolic inhibitor rather than a therapeutic target. Its primary biological action involves the high-affinity binding to the ferric (Fe3+) iron of the heme a3-CuB binuclear center in cytochrome c oxidase, also known as Complex IV of the mitochondrial electron transport chain (PubChem CID 190214; Smith et al., 1991). This binding effectively blocks the final step of cellular respiration, preventing the reduction of oxygen to water and halting the production of ATP, which leads to rapid cellular and systemic hypoxia (StatPearls, "Sodium Azide Toxicity"). In addition to its toxicological significance, the azide functional group is a cornerstone of bioorthogonal chemistry, particularly in the copper-catalyzed azide-alkyne cycloaddition (click chemistry) used for site-specific labeling of biomolecules (Kolb et al., 2001). While certain drugs like zidovudine (AZT) incorporate an azide group into their structure to inhibit viral enzymes, the azide ion itself is not a target for drug development and is primarily encountered as a laboratory reagent or a hazardous environmental toxin.

Other names
Azide ionTrinitrideHydrazoic acid anionSodium azide (as salt)
02

Mechanism of action

Azide inhibits mitochondrial respiration by binding to the heme a3-CuB site of cytochrome c oxidase (Complex IV), preventing electron transfer to oxygen.

03

Biological functions

Inhibition of cytochrome c oxidase (Complex IV)Inhibition of oxidative phosphorylationBioorthogonal labeling (Click chemistry)
04

Disease associations

Chemical poisoningMitochondrial dysfunctionMetabolic acidosis
05

Safety considerations

Acute systemic toxicityRespiratory failureSevere hypotensionSeizuresPotential for environmental hazard
06

Biomarkers

Blood lactate levels (elevation due to mitochondrial inhibition)Arterial blood gas (metabolic acidosis)Cytochrome c oxidase activity levels

Beyond the preview

Go deeper on Azide (N3-).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azide (N3-).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call